27. Evaluating the impact of expanded low-risk behavior guidelines with PrEP use on recruitment of participants into HIV Vaccine Trials Network (HVTN) Phase 1 studies.
27.
Anis El Marzouki
A qualitative online survey study assessing the willingness to participate in Phase 1 HIV vaccine trials among men who have sex with men (MSM) and transgender individuals on pre-exposure prophylaxis (PrEP) in New York City, following the expansion of eligibility to include individuals on PrEP in HIV vaccine research studies.
